Creative Biolabs-Lipid Based Drug Delivery

Ufasomes

Scientists at Creative Biolabs are expert in targeted delivery system research. We have a series of innovative and advanced platforms to provide fast and convenient liposome development services for our worldwide customers. Currently, we can provide affordable, high-quality ufasomes-based drug delivery services for diseases diagnosis and therapeutic with unbeatable rapid turnaround times.

Introduction

Ufasomes (unsaturated fatty acid vesicles) are suspensions of closed lipid bilayers that consist of fatty acids, and their ionized species (soap) which are restricted to narrow pH range from 7 to 9. In ufasomes, fatty acid molecules are targeted where their hydrocarbon tails are directed toward the membrane interior and the carboxyl groups are in contact with water. The formation of ufasomes is considered to result from associative interaction in mixtures of fully ionized and unionized fatty acids at pH > 7.0. Stability of ufasomes relies on suitable selection of fatty acid, amount of cholesterol, buffer, pH range, amount of lipoxygenase, and the presence of divalent cations. Recent innovative improvement renders advancement to formulate ufasomes with tailorable features such as extension of pH range, insensitivity toward divalent cations, and enhanced stability.

Fig.1 Structure of ufasomes made of unsaturated fatty acids. (Creative Biolabs Original)Fig.1 Structure of ufasomes made of unsaturated fatty acids.

Ufasomes-based Drug Delivery

Ufasomes have advantages as vehicles for the oral administration of poorly absorbable drugs. The effect of oleic acid vesicles (ufasomes) on the intestinal absorption of entrapped carboxyfluo-rescein (CF) is explored by an in situ closed-loop method in rats. Entrapment of CF in ufasomes promotes the absorption of CF at the earlier stage following intraduodenal administration, and the threshold concentration of the fatty acid for facilitating the absorption of CF is approximately 8 mM. The absorption of CF from the large intestine is enhanced much more effectively than from the small intestine. These studies suggest that ufasomes have potential as drug delivery system for the oral administration of poorly absorbable drugs. In addition, ufasomes have been considered as pre-biotic models for cellular compartments, thus, which also can be used for the horizontal transfer of genes from plants either soil-microbes or to environment and have more stabilized membrane than liposomes.

Features of Our Ufasomes-based Drug Delivery

  • First-class platform
  • Professional scientist
  • Timely and high-effective
  • Cost-effective and high-quality

Creative Biolabs is specialized in the targeted drug delivery system design and preparation that are suitable for a number of disease therapies. Our ufasomes-based drug delivery services may promote the drug administration and treatment of diseases for our worldwide customers. Moreover, we offer customized solutions for our clients to meet every specific research requirement. Please contact us to experience the value of our expert services.

For Research Use Only. Not For Clinical Use

Supports

Formulation Science Background of Liposome Research Highlights
Resources Technical Supports Featured Services Knowledge Center
Optimizing LNP Molar Ratios for Transfection Efficiency
Scalability Challenges in mRNA-LNP Manufacturing
Beyond mRNA: LNP Delivery for CRISPR/Cas9
Cationic Lipids Evolution: DOTAP to Ionizable Lipids
LNP Storage Stability: Lyophilization vs. Liquid
Modulating LNP Biodistribution: Overcoming Liver Accumulation
Active vs. Passive Targeting (EPR): A Guide to Tumor Drug Delivery
Immunoliposomes: Comparing Pre-insertion vs. Post-insertion Techniques
Crossing the BBB: Advances in Transferrin and Peptide-Modified Liposomes
pH-Responsive Liposomes for Tumor Microenvironment
Thermosensitive Liposomes combined with HIFU
Aptamer-Modified Liposomes: A Cost-Effective Antibody Alternative
Ethosomes vs Transfersomes for Dermal Delivery
Strategies for Encapsulating Poorly Water-Soluble Small Molecules in Liposomes
Multivesicular Liposomes: The Architecture of Sustained Release
Mechanisms of Liposomal Adjuvants in Enhancing Vaccine Immune Response
Protecting Enzymatic Activity: Liposomal Encapsulation Strategies for Enzymes
Cryo-TEM vs. DLS: Interpreting Discrepancies in Liposome Particle Size Data
Validating In Vitro Release Methods: Dialysis vs. Sample Separation Techniques
Predicting Long-Term Stability of Liposomal Suspensions using Zeta Potential
Troubleshooting Low Liposome Encapsulation Efficiency
Application of Multi-omics Analysis in Liposome Toxicology Assessment
The Ultimate Guide to Liposome Preparation
Fluorescent Liposomes for Cellular Uptake: Labeling, Controls, and Troubleshooting
How to Design Stealth Liposomes for Long Circulation
Homemade vs. Commercial Kits: Why Standardization Matters in Liposome Research

Online Inquiry